The ATTAIN-MAINTAIN Phase 3 trial specifically evaluated this scenario, testing whether patients who had achieved weight loss with injectable GLP-1 receptor agonists (semaglutide or tirzepatide) could switch to oral orforglipron while maintaining their weight loss
For the best chance of finding appropriate compression garments, patients can work with an experienced therapist or compression fitter to ensure accurate fit
Nonetheless, insights into the detoxification effect of Gsts on antifungal drugs are limited
Medical treatment
Ethics declarations Conflict of interests AA received honoraria for speaker activities, for serving on advisory boards, or consultancy from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Amarin, Bruno Farmaceutici, Amgen, Novo Nordisk, and Sanofi
64:269-281 [PubMed: 27916783] 335